Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantum Scan Holdings is a medical technology company focused on advanced healthcare technologies, specifically in the preventive diagnosis and prognosis sectors. In early 2026, it became a strategic partner of Scilex Holding Company, which invested $47.5 million to acquire a significant equity stake. The company is characterized by its focus on revenue-generation through advanced medical platforms and integrated analytics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantum Scan Holdings.